Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Non-Current Deferred Tax Liability (2016 - 2024)

Amn Healthcare Services (AMN) has disclosed Non-Current Deferred Tax Liability for 12 consecutive years, with $17.3 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Non-Current Deferred Tax Liability fell 44.82% year-over-year to $17.3 million, compared with a TTM value of $17.3 million through Sep 2024, down 44.82%, and an annual FY2023 reading of $23.3 million, up 2.8% over the prior year.
  • Non-Current Deferred Tax Liability was $17.3 million for Q3 2024 at Amn Healthcare Services, down from $20.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $104.3 million in Q1 2020 and bottomed at $7.0 million in Q2 2023.
  • Average Non-Current Deferred Tax Liability over 5 years is $46.5 million, with a median of $47.8 million recorded in 2021.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 419.26% in 2020, then crashed 86.3% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $67.2 million in 2020, then decreased by 28.85% to $47.8 million in 2021, then crashed by 52.5% to $22.7 million in 2022, then rose by 2.8% to $23.3 million in 2023, then dropped by 26.04% to $17.3 million in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for AMN at $17.3 million in Q3 2024, $20.6 million in Q2 2024, and $15.5 million in Q1 2024.